Gu, Bai-Wei <br/><br/>
Variant-type PML-RAR(alpha) fusion transcript in acute promyelocytic leukemia: use of a cryptic coding sequence from intron 2 of the RAR(alpha) gene and identification of a new clinical subtype resistant to retinoic acid therapy.  [electronic resource] 

 -  Proceedings of the National Academy of Sciences of the United States of America  May 2002 
 - 7640-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0027-8424 
<br/><br/><label>Standard No.: </label>10.1073/pnas.112194799  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Base Sequence<br/>Drug Resistance, Neoplasm--genetics<br/>Genetic Variation<br/>Humans<br/>Introns<br/>Leukemia, Promyelocytic, Acute--classification<br/>Molecular Sequence Data<br/>Neoplasm Proteins--genetics<br/>Oncogene Proteins, Fusion--genetics<br/>Receptors, Retinoic Acid--genetics<br/>Retinoic Acid Receptor alpha<br/>Retinoid X Receptors<br/>Sequence Alignment<br/>Sequence Analysis, DNA<br/>Sequence Homology, Nucleic Acid<br/>Transcription Factors--genetics<br/>Transcription, Genetic<br/>Tretinoin--therapeutic use